arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

Jaguar Health, Inc.

JAGX
$0.95 ▲ +0.01 (+1.31%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
50 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
9
Health
Poor
Bearish
auto_awesome

Analytical Summary

Jaguar Health, Inc. faces fundamental challenges. The fundamentals warrant careful consideration of downside risks.

Market Cap
Dividend Yield
Revenue Growth 815.6%
Op. Margin 50.2%
ROIC None
FCF / Share $17.12
Trailing P/E
Price / Book
FCF Yield 1802.1%
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

50-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$20.27M
↑ +815.6%
Net Income Profit after all expenses
$8.72M
↑ +137.6%
Operating Margin Operating profit as % of sales
50.2%
↑ +121.4% 0th
FCF / Share Free cash flow per share
$17.12
↑ +652.5%
Long-Term Debt Long-term obligations
$10.77M
↓ -1.0%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
0
Financial Health
6
Cash Quality
37

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 13 years · 50 quarters